Studies have reported that Dcn as a multivalent therapeutic agent against cancer by engaging multiple receptor tyrosine kinases like EGFR, Met and VEGFR2 [25], and Dcn deficiency promoted epithelial-mesenchymal transition and colorectum cancer metastasis [26]. This evidence concerns the gene NTRK1 and cancer.